Cargando…
Advantages of multi-arm non-randomised sequentially allocated cohort designs for Phase II oncology trials
BACKGROUND: Efficient trial designs are required to prioritise promising drugs within Phase II trials. Adaptive designs are examples of such designs, but their efficiency is reduced if there is a delay in assessing patient responses to treatment. METHODS: Motivated by the WIRE trial in renal cell ca...
Autores principales: | Mossop, Helen, Grayling, Michael J., Gallagher, Ferdia A., Welsh, Sarah J., Stewart, Grant D., Wason, James M. S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8770479/ https://www.ncbi.nlm.nih.gov/pubmed/34750494 http://dx.doi.org/10.1038/s41416-021-01613-5 |
Ejemplares similares
-
Exact group sequential designs for two-arm experiments with Poisson distributed outcome variables
por: Grayling, Michael J., et al.
Publicado: (2021) -
Group sequential designs for stepped-wedge cluster randomised trials
por: Grayling, Michael J, et al.
Publicado: (2017) -
A web application for the design of multi-arm clinical trials
por: Grayling, Michael J., et al.
Publicado: (2020) -
The WIRE study a phase II, multi-arm, multi-centre, non-randomised window-of-opportunity clinical trial platform using a Bayesian adaptive design for proof-of-mechanism of novel treatment strategies in operable renal cell cancer – a study protocol
por: Ursprung, Stephan, et al.
Publicado: (2021) -
An optimised multi-arm multi-stage clinical trial design for unknown variance
por: Grayling, Michael J., et al.
Publicado: (2018)